Minerva Neurosciences, Inc. Share Price Today: Live Updates & Key Insights

Minerva Neurosciences, Inc. share price today is $7.58, up -6.57%. The stock opened at $8 against the previous close of $8.07, with an intraday high of $8.13 and low of $7.52.

Minerva Neurosciences, Inc. Share Price Chart

Minerva Neurosciences, Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Minerva Neurosciences, Inc. Share Price Performance

$7.58 -0.0657(-6.57%) NERV at 23 Mar 2026 02:26 PM Biotechnology
Lowest Today 7.52
Highest Today 8.13
Today’s Open 8
Prev. Close 8.07
52 Week High 8.80
52 Week Low 1.15
Day’s Range: Low 7.52 High 8.13
52-Week Range: Low 1.15 High 8.80
1 day return -
1 Week return -2.94
1 month return +18.22
3 month return +87.4
6 month return +264.9
1 year return +430.76
3 year return +362.8
5 year return -68.26
10 year return -

Minerva Neurosciences, Inc. Institutional Holdings

Vivo Capital, LLC 9.99

Federated Hermes Kaufmann Growth 7.25

Adage Capital Partners Gp LLC 6.56

Farallon Capital Management, L.L.C. 5.47

Ally Bridge Group (NY) LLC 3.83

Spruce Street Capital LP 3.83

Federated Hermes Inc 3.12

Federated Hermes Kaufmann R 2.10

Federated Hermes Kaufmann Small Cap A 1.77

Longwood Capital Partners LLC 1.64

Federated Hermes Kaufmann Small Cap Grow 1.23

Vanguard Group Inc 0.58

Vanguard Total Stock Mkt Idx Inv 0.40

Renaissance Technologies Corp 0.34

Millennium Management LLC 0.32

BlackRock Inc 0.17

Geode Capital Management, LLC 0.16

Vanguard Institutional Extnd Mkt Idx Tr 0.12

Apella Capital, LLC 0.10

Fidelity Extended Market Index 0.07

Federated Hermes Kaufmann II P 0.06

Blackrock Extended Mkt Fund CF 0.06

Two Sigma Investments LLC 0.05

Extended Equity Market Fund K 0.05

Fidelity Total Market Index 0.05

Acadian Asset Management LLC 0.04

State Street Corp 0.04

LUX IM Global Medtech HX 0.03

Morgan Stanley - Brokerage Accounts 0.03

Fidelity Series Total Market Index 0.02

Spartan Extended Market Index Pool F 0.01

Fidelity Nasdaq Composite Index 0.01

Northern Trust Extended Eq Market Idx 0.01

NT Ext Equity Mkt Idx Fd - L 0.01

Spartan Total Market Index Pool G 0.01

NT Ext Equity Mkt Idx Fd - NL 0.01

Vanguard Instl Ttl Stck Mkt Idx Tr 0.01

Royal Bank of Canada 0.01

Tower Research Capital LLC 0.00

CWM, LLC duplicate 0.00

Minerva Neurosciences, Inc. Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Minerva Neurosciences, Inc. Fundamentals

Market Cap 26.92 M

PB Ratio 2.6783

PE Ratio 0.0

Enterprise Value 246.15 M

Total Assets 97.97 M

Volume 2259252

Minerva Neurosciences, Inc. Company Financials

Annual Revenue FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:41175600 41.2M

Annual Profit FY24:null 0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:41175600 41.2M

Annual Net worth FY24:1438865000 1438.9M, FY23:-27708951 -27.7M, FY22:-38986026 -39.0M, FY21:-49905952 -49.9M, FY20:1940771 1.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:42218 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-1361 -0.0M, Q2/2025:-1360 -0.0M, Q1/2025:21109 0.0M, Q3/2024:-5618 -0.0M, Q2/2024:-7746 -0.0M

Quarterly Net worth Q3/2025:-2743954 -2.7M, Q2/2025:-3258588 -3.3M, Q1/2025:-3752972 -3.8M, Q3/2024:22513205 22.5M, Q2/2024:-8233487 -8.2M

About Minerva Neurosciences, Inc. & investment objective

Company Information Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.

Organisation Biotechnology

Employees 7

Industry Biotechnology

CEO Dr. Remy Luthringer Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Minerva Neurosciences, Inc. FAQs

What is the share price of Minerva Neurosciences, Inc. today?

The current share price of Minerva Neurosciences, Inc. is $7.58.

Can I buy Minerva Neurosciences, Inc. shares in India?

Yes, Indian investors can buy Minerva Neurosciences, Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Minerva Neurosciences, Inc. shares in India?

You can easily invest in Minerva Neurosciences, Inc. shares from India by:

Can I buy fractional shares of Minerva Neurosciences, Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Minerva Neurosciences, Inc.?

Minerva Neurosciences, Inc. has a market cap of $26.92 M.

In which sector does Minerva Neurosciences, Inc. belong?

Minerva Neurosciences, Inc. operates in the Biotechnology sector.

What documents are required to invest in Minerva Neurosciences, Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Minerva Neurosciences, Inc.?

The PE ratio of Minerva Neurosciences, Inc. is N/A and the PB ratio is 2.68.